Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2.
Hiby SE, Apps R, Sharkey AM, Farrell LE, Gardner L, Mulder A, Claas FH, Walker JJ, Redman CW, Morgan L, Tower C, Regan L, Moore GE, Carrington M, Moffett A.
Hiby SE, et al. Among authors: moffett a.
J Clin Invest. 2010 Nov;120(11):4102-10. doi: 10.1172/JCI43998. Epub 2010 Oct 25.
J Clin Invest. 2010.
PMID: 20972337
Free PMC article.